vTv Therapeutics Inc. - 8-K Filing
vTv Therapeutics Inc. held its 2026 Annual Meeting of Stockholders on June 26, 2026, where seven director nominees were elected to the Board with varying levels of support; Fahed Al Marzooqi and Richard S. Nelson received over 90% 'for' votes (2,395k), while others like Daniel K. Spiegelman had lower approval at ~48%. Stockholders also ratified Ernst & Young LLP as independent auditors with strong backing (2,964k for) and approved executive compensation on a nonbinding advisory vote by 686k votes in favor. (Items: 5.07 Submission of Matters to a Vote of Security Holders)
Tickers: $VTVT